Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Sample	Treatment
Reversed phase NEGATIVE ION MODE	N-carbamoylaspartate	0.3599	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	N-carbamoylaspartate	0.3599	Peak area	Feces	Saline
Reversed phase NEGATIVE ION MODE	N-carbamoylaspartate	0.4423	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	N-carbamoylaspartate	0.5021	Peak area	Feces	Saline
Reversed phase NEGATIVE ION MODE	N-carbamoylaspartate	0.5561	Peak area	Feces	Saline
Reversed phase NEGATIVE ION MODE	N-carbamoylaspartate	0.7665	Peak area	Feces	Saline
Reversed phase NEGATIVE ION MODE	N-carbamoylaspartate	0.8867	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	N-carbamoylaspartate	0.9386	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	N-carbamoylaspartate	1.0614	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	N-carbamoylaspartate	1.5370	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	N-carbamoylaspartate	1.7461	Peak area	Feces	Saline
Reversed phase NEGATIVE ION MODE	N-carbamoylaspartate	2.2316	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	N-carbamoylaspartate	2.4094	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	N-carbamoylaspartate	8.7075	Peak area	Feces	Saline
Reversed phase NEGATIVE ION MODE	N-carbamoylaspartate	14.6958	Peak area	Feces	Saline